Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 117 clinical trials
Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

versus SMT alone in subjects with decompensated cirrhosis and ascites. The study population will consist of subjects being discharged after hospitalization for acute decompensation of liver cirrhosis

  • 08 May, 2021
  • 64 locations
Study Looking at Biomarkers in Ovarian Cancer

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the

ovarian cancer
  • 20 Apr, 2021
  • 5 locations
A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

The study is designed to study the efficacy of IV OsrHSA or positive control HSA (10 g and 20 g IV everyday) for 14 days. After a screening period of up to 14 days, the eligible subjects will be randomized in a 4:1 ratio to OsrHSA and positive control HSA, …

  • 15 Apr, 2021
  • 1 location
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites

The safety and tolerability of single-dose of SCB-313 will be evaluated by intraperitoneal injection; The safety and tolerability of repeated-dose of SCB-313 will be evaluated by intraperitoneal injection once a day for 3 days, and the maximum tolerated dose (MTD) of SCB-313 will be determined;

absolute neutrophil count
intraperitoneal injection
platelet count
serum pregnancy test
  • 28 Jan, 2021
  • 1 location
Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

The aim of this study is to evaluate difference in the rate of recovery of intestinal motility according to different ascites replacement strategy after living donor liver transplantation.

  • 26 Jan, 2021
  • 1 location
Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites

Assessment of effectiveness and local immune activation of Oncolytic Viruses H101 in patients with refractory malignant ascites.

  • 24 Apr, 2021
  • 1 location
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

oxaliplatin intravenous injection as first-line treatment in gastric or gastroesophageal junctional adenocarcinoma with malignant ascites.

  • 23 Jan, 2021
  • 1 location
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective Randomized Phase II Clinical Trial

The purpose of this study is to evaluate response to neoadjuvant chemotherapy by imaging and observation of anatomical and biological indicators (i.e. ascites or continuous measurement of

combination chemotherapy
tumor markers
cancer antigen 125
  • 07 Nov, 2020
  • 1 location
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

This is a randomized, multicenter, open, controlled Post-Marketing Study. 396 patients who were histopathology or exfoliated cell pathology of pleural and ascites confirmed with epithelial

  • 24 Jan, 2021
  • 1 location
Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices

varices, and allows for assessment of para-esophageal varices, varices in other body locations, ascites, other signs of portal hypertension, patency of liver vasculature, and detection, diagnosis and

  • 25 Jan, 2021
  • 1 location